These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12560463)

  • 1. Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate.
    Davids V; Kidson SH; Hanekom GS
    Mol Pathol; 2003 Feb; 56(1):43-51. PubMed ID: 12560463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.
    Bostick PJ; Morton DL; Turner RR; Huynh KT; Wang HJ; Elashoff R; Essner R; Hoon DS
    J Clin Oncol; 1999 Oct; 17(10):3238-44. PubMed ID: 10506625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction.
    Goydos JS; Ravikumar TS; Germino FJ; Yudd A; Bancila E
    J Am Coll Surg; 1998 Aug; 187(2):182-8; discussion 188-90. PubMed ID: 9704966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.
    Rutkowski P; Nowecki ZI; van Akkooi AC; Kulik J; Wanda M; Siedlecki JA; Eggermont AM; Ruka W
    Ann Surg Oncol; 2010 Dec; 17(12):3314-23. PubMed ID: 20607422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
    Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
    Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic assessment of melanoma sentinel nodes: a role for molecular analysis using quantitative real-time reverse transcription-PCR for MART-1 and tyrosinase messenger RNA.
    Abrahamsen HN; Sorensen BS; Nexo E; Hamilton-Dutoit SJ; Larsen J; Steiniche T
    Clin Cancer Res; 2005 Feb; 11(4):1425-33. PubMed ID: 15746042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma.
    Hochberg M; Lotem M; Gimon Z; Shiloni E; Enk CD
    Br J Dermatol; 2002 Feb; 146(2):244-9. PubMed ID: 11903234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases].
    Riccioni L; Farabegoli P; Nanni O; Morigi F; Polverelli M; Landi G; Giangaspero F
    Pathologica; 2002 Aug; 94(4):190-5. PubMed ID: 12325417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
    Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; Edwards MJ; Martin RC; Lewis AM; Stromberg AJ; Conrad AJ; Hagendoorn L; Albrecht J; McMasters KM
    J Clin Oncol; 2006 Jun; 24(18):2849-57. PubMed ID: 16782924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma.
    Curry BJ; Myers K; Hersey P
    J Clin Oncol; 1998 May; 16(5):1760-9. PubMed ID: 9586889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.
    Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C
    Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma-associated antigens as messenger RNA detection markers for melanoma.
    Sarantou T; Chi DD; Garrison DA; Conrad AJ; Schmid P; Morton DL; Hoon DS
    Cancer Res; 1997 Apr; 57(7):1371-6. PubMed ID: 9102226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.
    Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry.
    Blaheta HJ; Schittek B; Breuninger H; Maczey E; Kroeber S; Sotlar K; Ellwanger U; Thelen MH; Rassner G; Bültmann B; Garbe C
    Int J Cancer; 1998 Aug; 79(4):318-23. PubMed ID: 9699521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.
    Goto Y; Ferrone S; Arigami T; Kitago M; Tanemura A; Sunami E; Nguyen SL; Turner RR; Morton DL; Hoon DS
    Clin Cancer Res; 2008 Jun; 14(11):3401-7. PubMed ID: 18519770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes.
    Bieligk SC; Ghossein R; Bhattacharya S; Coit DG
    Ann Surg Oncol; 1999; 6(3):232-40. PubMed ID: 10340881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.
    Bilchik AJ; Saha S; Wiese D; Stonecypher JA; Wood TF; Sostrin S; Turner RR; Wang HJ; Morton DL; Hoon DS
    J Clin Oncol; 2001 Feb; 19(4):1128-36. PubMed ID: 11181678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods.
    Rimoldi D; Lemoine R; Kurt AM; Salvi S; Berset M; Matter M; Roche B; Cerottini JP; Guggisberg D; Krischer J; Braun R; Willi JP; Antonescu C; Slosman D; Lejeune FJ; Liénard D;
    Melanoma Res; 2003 Oct; 13(5):511-20. PubMed ID: 14512793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay.
    Palmieri G; Ascierto PA; Cossu A; Mozzillo N; Motti ML; Satriano SM; Botti G; Caracò C; Celentano E; Satriano RA; Lissia A; Tanda F; Pirastu M; Castello G;
    J Clin Oncol; 2001 Mar; 19(5):1437-43. PubMed ID: 11230489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.